cirrhotic portal hypertension
Conditions
Interventions
experimental group:Laparoscopic splenectomy in combination with EVL
control group:periesophagogastric devascularization
Sponsors
the Third affiliated hospital of Sun Yat-sen university
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) the age of 18 years old or more, or less 70 years old; Gender not limited; (2) the clinical diagnosis of hepatitis b cirrhosis portal hypertension andmassive haemorrhage of upper gastrointestinal tract, surgical treatment for the first time; (3) under gastroscope confirmed severe varicose vein of the esophagus; (4) the Child - Pugh class for A or B, scoring nine points or less. (5) 50*10^9/L or less platelet; (6) voluntarily signed informed consent.
Exclusion criteria
Exclusion criteria: (1) to form or the found a history of malignant tumor; (2) antibodies to HIV andHCV antibody positive; (3) immunodeficiency disease or autoimmune diseases such as rheumatoid arthritis, bergers disease, multiple sclerosis andtype 1 diabetes, etc.) history; (4) with other organs function failure; (5) with mental illness.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| upper gastrointestinal bleeding; | — |
Countries
China
Contacts
Public ContactBo Liu
Outcome results
None listed